Академический Документы
Профессиональный Документы
Культура Документы
INTRODUCTION
There is a major gap between what can be achieved with modern asthma management
sand what is currently being achieved. One of the main reasons for this is a lack of recognition of
asthma control and the requirement for more effective treatmentit is only through identifying
those patients with uncontrolled asthma that appropriate treatment will be prescribed. In part, the
difficulty in the assessment of control relates to the lack of a clear therapeutic target in asthma.
This contrasts with other chronic diseases such as hypertension or diabetes where treatment is
prescribed in order to achieve a definite therapeutic target. One approach to this difficulty is to
develop a simple test which is a screening tool to identify patients with poorly controlled asthma.
The Asthma Control Test (ACT) has been developed and validated for this purpose. It involves
patients completing a simple written questionnaire of 5 questions, from which a score (out of 25)
is obtained. It has been shown that the ACT is a simple, quick and accurate tool for assessing
asthma control and it has been shown to be responsive to changes in asthma control over time. It
can easily be incorporated into the routine assessment of patients with asthma and enable busy
healthcare professionals to more easily identify patients whose asthma control can be improved,
enabling changes to their management to be made and there by improve outcomes.(1)
DEFINITION
Asthma is a chronic respiratory disease that is mainly managed in primary care setting. In
the global initiative for asthma (GINA) 2006 guideline, achieving and maintaining clinical
control is highlighted as the goal asthma management. So far in China, an effective and
convenient means for evaluating asthma control has not been available in primary care settings,
especially in places where in spirometry is unavailable. In 2004, Nathan et al developed an easy
assessment tool for asthma control, know as the asthma control test (ACT).(2)
corresponding to a high level of symptoms and therefore poor asthma control. Studies have shown
that the ACT score effectively discriminates between patients who differ in asthma control, is
responsive to changes in control, and can discriminate between groups of patients in different lung
function ranges. The ACT score is highly effective as a screen for uncontrolled asthma and can
correctly predict GINA-defined partly controlled or uncontrolled asthma in over 90% of cases. A
score of 2025 means that a patients asthma is controlled. A score of 15-19 means that it may be
possible to increase the level of asthma control and a full review of the treatment plan, including
education on inhaler technique and the important of compliance with treatment, is warranted. A
score of 14 or less indicates that asthma is poorly or not controlled and that an urgent review of
and changes to the patients management are needed. Although there are no randomised studies
that demonstrate that use of the ACT translates into better asthma control, its use is highly likely
to improve patient outcomes as asthma therapy can be confidently adjusted up if control is
demonstrated to be poor. (1)
RESULTS
Revision of the questionnaire
The cognitive debriefing showed that most patients understood four of the five question.
However, the fourth question caused confusion as it asked rescue medication usage but
some patients answered about preventive medication.
Characteristics of study patients
A total 360 patients were invite to participate in the study; 323 (90%)of mean age 36
years (range 12-80) agreed to participate. Females comprised 57% of the participants
with a mean percentage predicted FEV 1 and PEF of 86% and 88,6%, respectively, and
mean ACT score of 20,5. Other characteristics are described in table 1, in which GINA
stage 3 is prominent (28%), but in general the patients were equally distributed among
the four stage. Most of the patients were using preventive medication; the majority had
controlled asthma according to both GINA and ACT criteria and were continued on the
same treatment after their visit.
Responsiveneses of the ACT to specialist treatment modivication
The ACT scores for groups receiving different asthma treatment decesions after medical
assessment are shown in Table 3. The mean Ac score was similar for those in whom
treatment was either maintained or stepped down (p=0,9) but much lower in those in
whom treatment was stepped up. There was a significant correlation beteween the ACT
score and asthma treatment modification (Spearmans r=-0,36, p<0,001).Relationship
between ACT score and %FEV1 and %PEF. The pearson coefficient between the ACT
score and %PEV1 was 0,35 (p<0,001) and between the ACT score and %PEF it was
0,26(p<0,001).
70%, specifity of 73%. PPV of 89%, NPV of 79%, positive LR of 9.6, negative LR of
0.3, and s correctly classified rate of 83%.
Agreement between ACT and GINA in classifying three levels of asthma control.
The kappa value was 0.55 ( table 2), indicating a moderate level of level of agreement
beyond chance between the two rating systems ( I=0.4-0.6). both rating system correctly
classifield 75% at three levels of asthma control. (4)
DISCUSSION
((